{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:41:33Z","timestamp":1792064493850,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04657-9","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T19:01:15Z","timestamp":1697310075000},"page":"3753-3758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of low-dose aspirin use for primary prevention with self-reported kidney stones prevalence: a cross-sectional study"],"prefix":"10.1007","volume":"41","author":[{"given":"Miaomiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-6089","authenticated-orcid":false,"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,14]]},"reference":[{"issue":"9507","key":"4657_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s0140-6736(06)68071-9","volume":"367","author":"OW Moe","year":"2006","unstructured":"Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet (London, England) 367(9507):333\u201344. https:\/\/doi.org\/10.1016\/s0140-6736(06)68071-9. (Epub 2006\/01\/3)","journal-title":"Lancet (London, England)"},{"issue":"1","key":"4657_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","volume":"62","author":"CD Scales Jr","year":"2012","unstructured":"Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Prevalence of kidney stones in the United States. Eur Urol 62(1):160\u20135. https:\/\/doi.org\/10.1016\/j.eururo.2012.03.052. (Epub 2012\/04\/14)","journal-title":"Eur Urol"},{"issue":"23","key":"4657_CR3","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","volume":"73","author":"HK Abdelaziz","year":"2019","unstructured":"Abdelaziz HK, Saad M, Pothineni NVK, Megaly M, Potluri R, Saleh M et al (2019) Aspirin for primary prevention of cardiovascular\u00a0events. J Am Coll Cardiol 73(23):2915\u201329. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.501. (Epub 2019\/06\/15)","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4657_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","volume":"321","author":"SL Zheng","year":"2019","unstructured":"Zheng SL, Roddick AJ (2019) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. Jama 321(3):277\u201387. https:\/\/doi.org\/10.1001\/jama.2018.20578. (Epub 2019\/01\/23)","journal-title":"Jama"},{"key":"4657_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/jaha.117.006328","volume":"6","author":"JR Van't Hof","year":"2017","unstructured":"Van\u2019t Hof JR, Duval S, Walts A, Kopecky SL, Luepker RV, Hirsch AT (2017) Contemporary primary prevention aspirin use by cardiovascular disease risk: impact of US preventive services task force recommendations, 2007\u20132015: a serial, cross-sectional study. J Am Heart Assoc 6:10. https:\/\/doi.org\/10.1161\/jaha.117.006328. (Epub 2017\/10\/05)","journal-title":"J Am Heart Assoc"},{"issue":"10186","key":"4657_CR6","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/s0140-6736(19)30541-0","volume":"393","author":"I Raber","year":"2019","unstructured":"Raber I, McCarthy CP, Vaduganathan M, Bhatt DL, Wood DA, Cleland JGF et al (2019) The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet (London, England) 393(10186):2155\u201367. https:\/\/doi.org\/10.1016\/s0140-6736(19)30541-0. (Epub 2019\/06\/22)","journal-title":"Lancet (London, England)"},{"issue":"6","key":"4657_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1042\/cs20171574","volume":"132","author":"A Devarajan","year":"1979","unstructured":"Devarajan A (1979) 2018 Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases. Clin Sci (London, England 1979) 132(6):615\u201326. https:\/\/doi.org\/10.1042\/cs20171574. (Epub 2018\/03\/22)","journal-title":"Clin Sci (London, England 1979)"},{"issue":"6","key":"4657_CR8","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.ekir.2017.06.001","volume":"2","author":"X Fan","year":"2017","unstructured":"Fan X, Kalim S, Ye W, Zhao S, Ma J, Nigwekar SU et al (2017) Urinary stone disease and cardiovascular disease risk in a rural Chinese population. Kidney Int Rep 2(6):1042\u20139. https:\/\/doi.org\/10.1016\/j.ekir.2017.06.001. (Epub 2017\/12\/23)","journal-title":"Kidney Int Rep"},{"issue":"13","key":"4657_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJMoa1412168","volume":"372","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL (2015) Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 372(13):1213\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1412168. (Epub 2015\/03\/17)","journal-title":"N Engl J Med"},{"key":"4657_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pmedr.2016.12.023","volume":"5","author":"M Stuntz","year":"2017","unstructured":"Stuntz M, Bernstein B (2017) Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States. Prev Med Rep 5:183\u2013186. https:\/\/doi.org\/10.1016\/j.pmedr.2016.12.023. (Epub 2017\/01\/11)","journal-title":"Prev Med Rep"},{"issue":"29","key":"4657_CR11","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al (2016) European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315\u201381. https:\/\/doi.org\/10.1093\/eurheartj\/ehw106. (Epub 2016\/05\/26)","journal-title":"Eur Heart J"},{"issue":"10152","key":"4657_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/s0140-6736(18)31924-x","volume":"392","author":"JM Gaziano","year":"2018","unstructured":"Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB et al (2018) Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet (London, England) 392(10152):1036\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(18)31924-x. (Epub 2018\/08\/31)","journal-title":"Lancet (London, England)"},{"issue":"16","key":"4657_CR13","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","volume":"379","author":"L Bowman","year":"2018","unstructured":"Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J et al (2018) Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med 379(16):1529\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1804988. (Epub 2018\/08\/28)","journal-title":"N Engl J Med"},{"issue":"16","key":"4657_CR14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR et al (2018) Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med 379(16):1509\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1805819. (Epub 2018\/09\/18)","journal-title":"N Engl J Med"},{"key":"4657_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03790-7","author":"JN Bamberger","year":"2021","unstructured":"Bamberger JN, Rosen DC, Khusid JA, Kaplan-Marans E, Gallante B, Kapoor A et al (2021) The impact of metabolic syndrome components on urinary parameters and risk of stone formation. World J Urol. https:\/\/doi.org\/10.1007\/s00345-021-03790-7. (Epub 2021\/07\/16)","journal-title":"World J Urol"},{"issue":"8","key":"4657_CR16","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1093\/ndt\/gfr703","volume":"27","author":"K Sakhaee","year":"2012","unstructured":"Sakhaee K, Capolongo G, Maalouf NM, Pasch A, Moe OW, Poindexter J et al (2012) Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant:Off Publ European Dial Transplant Assoc-Eur Ren Assoc 27(8):3201\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfr703. (Epub 2012\/01\/17)","journal-title":"Nephrol Dial Transplant:Off Publ European Dial Transplant Assoc-Eur Ren Assoc"},{"key":"4657_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1749-6632.1971.tb46905.x","volume":"179","author":"C Davison","year":"1971","unstructured":"Davison C (1971) Salicylate metabolism in man. Ann N Y. Acad Sci 179:249\u201368. https:\/\/doi.org\/10.1111\/j.1749-6632.1971.tb46905.x. (Epub 1971\/07\/06)","journal-title":"Ann N Y. Acad Sci"},{"issue":"2","key":"4657_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2165\/00003088-198510020-00004","volume":"10","author":"CJ Needs","year":"1985","unstructured":"Needs CJ, Brooks PM (1985) Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 10(2):164\u201377. https:\/\/doi.org\/10.2165\/00003088-198510020-00004. (Epub 1985\/03\/01)","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"4657_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/s0022-5347(17)67713-9","volume":"72","author":"HC Harlin","year":"1954","unstructured":"Harlin HC, Wiesel L (1954) Modification of urinary surface tension by oral glucuronic acid: its application in prophylaxis of urinary calculi. J Urol 72(6):1046\u20139. https:\/\/doi.org\/10.1016\/s0022-5347(17)67713-9. (Epub 1954\/12\/01)","journal-title":"J Urol"},{"issue":"11","key":"4657_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1056\/nejm195509152531102","volume":"253","author":"EL Prien","year":"1955","unstructured":"Prien EL, Walker BS (1955) Salicylate therapy of recurrent calcium urolithiasis. N Engl J Med 253(11):446\u201351. https:\/\/doi.org\/10.1056\/nejm195509152531102. (Epub 1955\/09\/15)","journal-title":"N Engl J Med"},{"issue":"3","key":"4657_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/s0022-5347(17)66572-8","volume":"77","author":"M Abrams","year":"1957","unstructured":"Abrams M (1957) Unfavorable results of acetylsalicylic acid in the treatment of recurrent urolithiasis. J Urol 77(3):372\u20136. https:\/\/doi.org\/10.1016\/s0022-5347(17)66572-8. (Epub 1957\/03\/01)","journal-title":"J Urol"},{"issue":"1","key":"4657_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/1529-0131(200001)43:1<103::Aid-anr13>3.0.Co;2-c","volume":"43","author":"D Caspi","year":"2000","unstructured":"Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R (2000) The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 43(1):103\u20138. https:\/\/doi.org\/10.1002\/1529-0131(200001)43:1%3c103::Aid-anr13%3e3.0.Co;2-c. (Epub 2000\/01\/22)","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4657_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kew293","volume":"56","author":"C Ben Salem","year":"2017","unstructured":"Ben Salem C, Slim R, Fathallah N, Hmouda H (2017) Drug-induced hyperuricaemia and gout. Rheumatology (Oxford, England) 56(5):679\u201388. https:\/\/doi.org\/10.1093\/rheumatology\/kew293. (Epub 2016\/08\/09)","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"4657_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jare.2017.04.005","volume":"8","author":"A Abou-Elela","year":"2017","unstructured":"Abou-Elela A (2017) Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review. J Advanced Res 8(5):513\u201327 (Epub 2017\/07\/28)","journal-title":"J Advanced Res"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04657-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04657-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04657-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T12:03:00Z","timestamp":1701518580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04657-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4657"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04657-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,14]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study involving human participants was reviewed and approved by The Wake Forest School of Medicine Institutional Review Board. The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}